| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction
|
Ho, William Y
|
|
2003
|
3 |
5 |
p. 431-437
7 p.
|
article
|
| 2 |
Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells
|
Rao, Dinesh S.
|
|
2003
|
3 |
5 |
p. 471-482
12 p.
|
article
|
| 3 |
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells
|
Don, Anthony S
|
|
2003
|
3 |
5 |
p. 497-509
13 p.
|
article
|
| 4 |
Cell fusion: A hidden enemy?
|
Duelli, Dominik
|
|
2003
|
3 |
5 |
p. 445-448
4 p.
|
article
|
| 5 |
Chk1 and Chk2 kinases in checkpoint control and cancer
|
Bartek, Jiri
|
|
2003
|
3 |
5 |
p. 421-429
9 p.
|
article
|
| 6 |
Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer
|
Forster, Alan
|
|
2003
|
3 |
5 |
p. 449-458
10 p.
|
article
|
| 7 |
FANCF methylation contributes to chemoselectivity in ovarian cancer
|
Olopade, Olufunmilayo I
|
|
2003
|
3 |
5 |
p. 417-420
4 p.
|
article
|
| 8 |
Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase
|
Zhao, Jean J
|
|
2003
|
3 |
5 |
p. 483-495
13 p.
|
article
|
| 9 |
PDGF receptors as cancer drug targets
|
Pietras, Kristian
|
|
2003
|
3 |
5 |
p. 439-443
5 p.
|
article
|
| 10 |
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease
|
Cools, Jan
|
|
2003
|
3 |
5 |
p. 459-469
11 p.
|
article
|
| 11 |
Targeting oncogene dependence and resistance
|
Hingorani, Sunil R
|
|
2003
|
3 |
5 |
p. 414-417
4 p.
|
article
|
| 12 |
Transgenics at breaking-point
|
Prosser, Haydn
|
|
2003
|
3 |
5 |
p. 411-413
3 p.
|
article
|
Journal description